Keith Katkin
Director · 3 filings · Latest: Apr 30, 2026
Eledon Pharmaceuticals, Inc.
Emergent BioSolutions Inc.
Syndax Pharmaceuticals Inc
| Ticker | Owner | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total | SEC Filing |
|---|---|---|---|---|---|---|---|---|---|
EBS | Keith Katkin | Director | Apr 30, 2026 | Sale | $8.28 | 15,481 | $128.2K | 96,294 | |
EBS | KEITH KATKIN | — | Apr 30, 2026 | Proposed Sale | $8.28 | 15,481 | $128.1K | — | |
ELDN | Keith Katkin | Director | Jan 10, 2026 | Option Exercise | $0.00 | 8,575 | — | 8,575 | |
EBS | KEITH KATKIN | — | May 23, 2025 | Proposed Sale | $6.30 | 7,844 | $49.4K | — |